Trial Profile
Intra-Detrusor Onabotulinumtoxin a for Idiopatic Overactive Bladder Patients Refractory to Antimuscarinic Therapy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Mar 2015
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 29 Mar 2015 New trial record